The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma

Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-...

Full description

Saved in:
Bibliographic Details
Published inOral oncology Vol. 47; no. 11; pp. 1023 - 1031
Main Authors Yoon, Hye-Jung, Hong, Ji-Soo, Shin, Wui-Jung, Lee, Yoo-Jin, Hong, Kyoung-Ok, Lee, Jae-Il, Hong, Sam-Pyo, Hong, Seong-Doo
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 01.11.2011
Elsevier
Subjects
Online AccessGet full text
ISSN1368-8375
1879-0593
1879-0593
DOI10.1016/j.oraloncology.2011.07.019

Cover

Abstract Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)–CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) ( p = 0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC ( p = 0.015) and a high PCNA index ( p = 0.011). The in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells ( p < 0.05 and p < 0.01, respectively). In in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively ( p = 0.000 and p = 0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells.
AbstractList Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)-CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) (p=0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC (p=0.015) and a high PCNA index (p=0.011). The in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells (p<0.05 and p<0.01, respectively). In in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively (p=0.000 and p=0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells.Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)-CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) (p=0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC (p=0.015) and a high PCNA index (p=0.011). The in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells (p<0.05 and p<0.01, respectively). In in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively (p=0.000 and p=0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells.
Summary Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)–CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) ( p = 0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC ( p = 0.015) and a high PCNA index ( p = 0.011). The in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells ( p < 0.05 and p < 0.01, respectively). In in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively ( p = 0.000 and p = 0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells.
Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)–CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) ( p = 0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC ( p = 0.015) and a high PCNA index ( p = 0.011). The in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells ( p < 0.05 and p < 0.01, respectively). In in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively ( p = 0.000 and p = 0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells.
Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due mostly to late detection of this cancer in its advanced stages despite the easy accessibility of the oral cavity for regular examinations. Cripto-1 is a member of the epidermal growth factor (EGF)-CFC protein family and is involved in the activation of several different signaling pathways during embryonic development and cellular transformation. Although the Cripto-1 protein is overexpressed in several human cancers including breast, colon, cervix, gastric, and pancreatic cancer, no prior study has evaluated Cripto-1 expression in OSCC. Therefore, our aims in this study were to examine Cripto-1 expression in clinical samples of OSCC patients using immunohistochemistry, to analyze the correlation between Cripto-1 expression and clinicopathologic parameters, and to identify the oncogenic roles of Cripto-1 in OSCC cell lines. Both epithelial dysplasia (73.3%) and OSCC (55.5%) tissue samples showed significantly higher expression of Cripto-1 than normal mucosa (20%) (p=0.031). In the OSCC samples, there was a significant correlation between Cripto-1 expression and the histological differentiation of OSCC (p=0.015) and a high PCNA index (p=0.011). The in vitro cell proliferation assays demonstrated that recombinant human Cripto-1 (rhCripto-1) induced both SCC-4 and SCC-25 cells to proliferate as compared with control cells (p<0.05 and p<0.01, respectively). In in vitro migration assays, treatment of SCC-4 and SCC-25 cells with rhCripto-1 protein induced a 2.4-fold and 1.7-fold-increase in cell migration, respectively (p=0.000 and p=0.008, respectively). Taken together, our data suggest that Cripto-1 plays a role in the malignant transformation of the oral mucosa and is involved in the tumorigenesis and progression of OSCC by promoting the growth and migration of malignant cells.
Author Yoon, Hye-Jung
Lee, Jae-Il
Hong, Seong-Doo
Lee, Yoo-Jin
Hong, Kyoung-Ok
Hong, Ji-Soo
Shin, Wui-Jung
Hong, Sam-Pyo
Author_xml – sequence: 1
  givenname: Hye-Jung
  surname: Yoon
  fullname: Yoon, Hye-Jung
– sequence: 2
  givenname: Ji-Soo
  surname: Hong
  fullname: Hong, Ji-Soo
– sequence: 3
  givenname: Wui-Jung
  surname: Shin
  fullname: Shin, Wui-Jung
– sequence: 4
  givenname: Yoo-Jin
  surname: Lee
  fullname: Lee, Yoo-Jin
– sequence: 5
  givenname: Kyoung-Ok
  surname: Hong
  fullname: Hong, Kyoung-Ok
– sequence: 6
  givenname: Jae-Il
  surname: Lee
  fullname: Lee, Jae-Il
– sequence: 7
  givenname: Sam-Pyo
  surname: Hong
  fullname: Hong, Sam-Pyo
– sequence: 8
  givenname: Seong-Doo
  surname: Hong
  fullname: Hong, Seong-Doo
  email: hongsd@snu.ac.kr
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25527580$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21824804$$D View this record in MEDLINE/PubMed
BookMark eNqNklur1DAUhYMc8Vz0L0gQxKfWnaZJGx9EHa9wwAePDz6FTLo7ZmyTOUkrzL83ZcYLB4R5SgjfXqystS_JmQ8eCXnCoGTA5PNtGaIZgrdhCJt9WQFjJTQlMHWPXLC2UQUIxc_yncu2aHkjzsllSlsAEEzAA3JesbaqW6gvyLeb70hjGJCGnq6i202hYNR5OuX3aR5DdBv0mFyixnd0F8MmYkou-GVg8UHT7WzGMCdqcRioNdE6H0bzkNzvzZDw0fG8Il_fv7tZfSyuP3_4tHp9XVjRiKkQtmpbYFXf8TVXkvdcIMtGu7rjkrVK9fUarbBYMdPZRpo1Slt3yHvFpJU1vyLPDrrZ2-2MadKjS4sV4zG70gpAVkpJmcnHR3Jej9jpXXSjiXv9O40MPD0CJlkz9NF469JfToiqES1k7sWBszGkFLH_gzDQS0V6q_-tSC8VaWh0rigPv7ozbN1kppzoFI0bTpN4e5DAnOtPh1En69Bb7FxEO-kuuNNkXt6RsYPzLv_8B-4xbcMcfW5OM50qDfrLsk7LNrHcTyOBZ4E3_xc41cUvSeziqg
CitedBy_id crossref_primary_10_2174_0929867325666180912104707
crossref_primary_10_1615_CritRevOncog_2022047207
crossref_primary_10_1002_jcb_29293
crossref_primary_10_1007_s13277_014_2695_1
crossref_primary_10_1097_MD_0000000000011781
crossref_primary_10_3390_ijms221810164
crossref_primary_10_1007_s00405_018_4960_1
crossref_primary_10_1007_s13277_014_2039_1
crossref_primary_10_1590_0001_3765202020200519
crossref_primary_10_1111_odi_13730
crossref_primary_10_7314_APJCP_2014_15_20_8549
crossref_primary_10_1016_j_toxrep_2019_05_013
crossref_primary_10_1007_s10006_020_00877_0
crossref_primary_10_1016_j_oraloncology_2018_11_001
crossref_primary_10_3390_cancers12061480
crossref_primary_10_1016_j_bjorl_2019_04_002
crossref_primary_10_1007_s12038_017_9700_y
crossref_primary_10_3892_mmr_2016_5126
crossref_primary_10_18632_oncotarget_5057
crossref_primary_10_1111_crj_13680
crossref_primary_10_2217_bmm_2019_0159
crossref_primary_10_3389_fonc_2022_830873
crossref_primary_10_1593_tlo_13427
crossref_primary_10_1007_s12291_020_00898_2
crossref_primary_10_1002_jcb_28015
crossref_primary_10_1016_j_oooo_2013_10_018
crossref_primary_10_1159_000518521
crossref_primary_10_1111_odi_13640
crossref_primary_10_1002_dvdy_338
crossref_primary_10_1016_j_ajpath_2012_02_031
Cites_doi 10.1093/jnci/dji011
10.1002/jcp.10072
10.1016/S0955-0674(97)80061-0
10.1002/jcp.20062
10.1677/erc.0.0070199
10.1016/j.ejso.2006.10.014
10.1242/dev.00859
10.1002/(SICI)1097-0215(19960103)65:1<51::AID-IJC9>3.0.CO;2-0
10.3748/wjg.v16.i5.571
10.1016/j.exer.2007.01.019
10.1006/excr.2001.5195
10.1172/JCI17788
10.1038/sj.onc.1208918
10.1016/S0959-8049(00)00033-2
10.1111/j.1365-2559.2008.02971.x
10.1158/0008-5472.CAN-03-3888
10.1016/j.oraloncology.2008.06.002
10.1038/sj.cdd.4400368
10.1101/gad.13.22.2905
10.1186/1471-2407-9-315
10.1111/j.1349-7006.1991.tb01929.x
10.1002/jcp.10375
10.1002/path.2083
10.1038/sj.onc.1208417
10.1080/08977190410001723290
10.1006/excr.2000.4881
10.1016/S0168-9525(00)02006-0
10.1128/MCB.01168-06
ContentType Journal Article
Copyright 2011 Elsevier Ltd
Elsevier Ltd
2015 INIST-CNRS
Copyright © 2011 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2011 Elsevier Ltd
– notice: Elsevier Ltd
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.oraloncology.2011.07.019
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Dentistry
EISSN 1879-0593
EndPage 1031
ExternalDocumentID 21824804
25527580
10_1016_j_oraloncology_2011_07_019
S1368837511007603
1_s2_0_S1368837511007603
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29N
3O-
4.4
457
4CK
4G.
53G
5RE
5VS
7-5
71M
8P~
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACGFS
ACIEU
ACIUM
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
X7M
XPP
Z5R
ZGI
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c575t-5c288012fd3b3963f35e1005d4d361899f4bec5ce21adc76abe6c4de3f916c643
IEDL.DBID .~1
ISSN 1368-8375
1879-0593
IngestDate Fri Sep 05 12:40:02 EDT 2025
Thu Apr 03 06:56:13 EDT 2025
Mon Jul 21 09:18:01 EDT 2025
Tue Jul 01 04:17:17 EDT 2025
Thu Apr 24 22:52:24 EDT 2025
Fri Feb 23 02:27:48 EST 2024
Sun Feb 23 10:19:38 EST 2025
Tue Aug 26 16:33:12 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Cell growth
Oral squamous cell carcinoma
Migration
Cripto-1
Cell proliferation
Cancerology
Stomatology
Oral cavity disease
ENT
Malignant tumor
Cancer
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2011 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c575t-5c288012fd3b3963f35e1005d4d361899f4bec5ce21adc76abe6c4de3f916c643
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1016/j.oraloncology.2011.07.019
PMID 21824804
PQID 900629966
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_900629966
pubmed_primary_21824804
pascalfrancis_primary_25527580
crossref_primary_10_1016_j_oraloncology_2011_07_019
crossref_citationtrail_10_1016_j_oraloncology_2011_07_019
elsevier_sciencedirect_doi_10_1016_j_oraloncology_2011_07_019
elsevier_clinicalkeyesjournals_1_s2_0_S1368837511007603
elsevier_clinicalkey_doi_10_1016_j_oraloncology_2011_07_019
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-11-01
PublicationDateYYYYMMDD 2011-11-01
PublicationDate_xml – month: 11
  year: 2011
  text: 2011-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Kidlington
PublicationPlace_xml – name: Kidlington
– name: England
PublicationTitle Oral oncology
PublicationTitleAlternate Oral Oncol
PublicationYear 2011
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Strizzi, Bianco, Hirota, Watanabe, Mancino, Hamada (b0150) 2007; 211
Wechselberger, Ebert, Bianco, Khan, Sun, Wallace-Jones (b0160) 2001; 266
Normanno, Bianco, Damiano, de Angelis, Selvam, Grassi (b0050) 1996; 2
Ebert, Wechselberger, Nees, Clair, Schaller, Martinez-Lacaci (b0155) 2000; 257
Adkins, Bianco, Schiffer, Rayhorn, Zafari, Cheung (b0025) 2003; 112
Bianco, Strizzi, Ebert, Chang, Rehman, Normanno (b0060) 2005; 97
Bianco, Strizzi, Rehman, Normanno, Wechselberger, Sun (b0030) 2003; 63
Bianco, Normanno, Salomon, Ciardiello (b0015) 2004; 22
Wu, Li, Wu, Weng, Li, Yao (b0075) 2009; 9
Wechselberger, Strizzi, Kenney, Hirota, Sun, Ebert (b0145) 2005; 24
Strizzi, Bianco, Normanno, Salomon (b0045) 2005; 24
Saeki, Stromberg, Qi, Gullick, Tahara, Normanno (b0085) 1992; 52
Hong, Lee, Park, Jeon, Bang, Park (b0125) 2009; 21
Warnakulasuriya (b0010) 2009; 45
Gray, Shani, Aung, Kelber, Vale (b0170) 2006; 26
Kuniyasu, Yoshida, Yokozaki, Yasui, Ito, Toge (b0080) 1991; 82
Normanno, De Luca, Bianco, Maiello, Carriero, Rehman (b0165) 2004; 198
Greene, Page, Fleming, Fritz, Balch, Haller (b0070) 2002
Robinson, Cobb (b0035) 1997; 9
Datta, Brunet, Greenberg (b0040) 1999; 13
Strizzi, Bianco, Normanno, Seno, Wechselberger, Wallace-Jones (b0065) 2004; 201
Shen, Schier (b0020) 2000; 16
.
Saloman, Bianco, Ebert, Khan, De Santis, Normanno (b0100) 2000; 7
Niemeyer, Persico, Adamson (b0140) 1998; 5
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010.
Mallikarjuna, Vaijayanthi, Krishnakumar (b0120) 2007; 84
Adamson, Minchiotti, Salomon (b0135) 2002; 190
Miyoshi, Ishii, Mimori, Sekimoto, Doki, Mori (b0130) 2010; 36
Gong, Yarrow, Carmalt, Kwun, Kennedy, Lin (b0105) 2007; 33
Morkel, Huelsken, Wakamiya, Ding, van de Wetering, Clevers (b0175) 2003; 130
Zhang, Zhao, Xin (b0095) 2010; 16
Panico, D’Antonio, Salvatore, Mezza, Tortora, De Laurentiis (b0090) 1996; 65
Zhong, Zhang, Jia, Shi, Niu, Du (b0115) 2008; 52
Ertoy, Ayhan, Saraç, Karaağaoğlu, Yasui, Tahara (b0110) 2000; 36
Xing, Hu, Pietersz, Hosick, McKenzie (b0055) 2004; 64
Shen (10.1016/j.oraloncology.2011.07.019_b0020) 2000; 16
Miyoshi (10.1016/j.oraloncology.2011.07.019_b0130) 2010; 36
Adamson (10.1016/j.oraloncology.2011.07.019_b0135) 2002; 190
Gray (10.1016/j.oraloncology.2011.07.019_b0170) 2006; 26
Datta (10.1016/j.oraloncology.2011.07.019_b0040) 1999; 13
Robinson (10.1016/j.oraloncology.2011.07.019_b0035) 1997; 9
Zhong (10.1016/j.oraloncology.2011.07.019_b0115) 2008; 52
Bianco (10.1016/j.oraloncology.2011.07.019_b0030) 2003; 63
Warnakulasuriya (10.1016/j.oraloncology.2011.07.019_b0010) 2009; 45
Normanno (10.1016/j.oraloncology.2011.07.019_b0165) 2004; 198
Strizzi (10.1016/j.oraloncology.2011.07.019_b0045) 2005; 24
Panico (10.1016/j.oraloncology.2011.07.019_b0090) 1996; 65
Ebert (10.1016/j.oraloncology.2011.07.019_b0155) 2000; 257
Kuniyasu (10.1016/j.oraloncology.2011.07.019_b0080) 1991; 82
Bianco (10.1016/j.oraloncology.2011.07.019_b0015) 2004; 22
Saloman (10.1016/j.oraloncology.2011.07.019_b0100) 2000; 7
Ertoy (10.1016/j.oraloncology.2011.07.019_b0110) 2000; 36
Wechselberger (10.1016/j.oraloncology.2011.07.019_b0145) 2005; 24
Niemeyer (10.1016/j.oraloncology.2011.07.019_b0140) 1998; 5
Hong (10.1016/j.oraloncology.2011.07.019_b0125) 2009; 21
Greene (10.1016/j.oraloncology.2011.07.019_b0070) 2002
Gong (10.1016/j.oraloncology.2011.07.019_b0105) 2007; 33
Zhang (10.1016/j.oraloncology.2011.07.019_b0095) 2010; 16
Mallikarjuna (10.1016/j.oraloncology.2011.07.019_b0120) 2007; 84
Strizzi (10.1016/j.oraloncology.2011.07.019_b0065) 2004; 201
Wu (10.1016/j.oraloncology.2011.07.019_b0075) 2009; 9
Strizzi (10.1016/j.oraloncology.2011.07.019_b0150) 2007; 211
Normanno (10.1016/j.oraloncology.2011.07.019_b0050) 1996; 2
Adkins (10.1016/j.oraloncology.2011.07.019_b0025) 2003; 112
Saeki (10.1016/j.oraloncology.2011.07.019_b0085) 1992; 52
Xing (10.1016/j.oraloncology.2011.07.019_b0055) 2004; 64
10.1016/j.oraloncology.2011.07.019_b0005
Wechselberger (10.1016/j.oraloncology.2011.07.019_b0160) 2001; 266
Bianco (10.1016/j.oraloncology.2011.07.019_b0060) 2005; 97
Morkel (10.1016/j.oraloncology.2011.07.019_b0175) 2003; 130
References_xml – volume: 52
  start-page: 3467
  year: 1992
  end-page: 3473
  ident: b0085
  article-title: Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors
  publication-title: Cancer Res
– volume: 130
  start-page: 6283
  year: 2003
  end-page: 6294
  ident: b0175
  article-title: Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation
  publication-title: Development
– volume: 97
  start-page: 132
  year: 2005
  end-page: 141
  ident: b0060
  article-title: Role of human cripto-1 in tumor angiogenesis
  publication-title: J Natl Cancer Inst
– volume: 211
  start-page: 36
  year: 2007
  end-page: 44
  ident: b0150
  article-title: Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice
  publication-title: J Pathol
– volume: 9
  start-page: 315
  year: 2009
  ident: b0075
  article-title: Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma
  publication-title: BMC Cancer
– volume: 36
  start-page: 563
  year: 2010
  end-page: 568
  ident: b0130
  article-title: TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer
  publication-title: Int J Oncol
– volume: 16
  start-page: 303
  year: 2000
  end-page: 309
  ident: b0020
  article-title: The EGF–CFC gene family in vertebrate development
  publication-title: Trends Genet
– volume: 2
  start-page: 601
  year: 1996
  end-page: 609
  ident: b0050
  article-title: Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides
  publication-title: Clin Cancer Res
– volume: 65
  start-page: 51
  year: 1996
  end-page: 56
  ident: b0090
  article-title: Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues
  publication-title: Int J Cancer
– volume: 190
  start-page: 267
  year: 2002
  end-page: 278
  ident: b0135
  article-title: Cripto: a tumor growth factor and more
  publication-title: J Cell Physiol
– volume: 64
  start-page: 4018
  year: 2004
  end-page: 4023
  ident: b0055
  article-title: Cripto: a novel target for antibody-based cancer immunotherapy
  publication-title: Cancer Res
– volume: 9
  start-page: 180
  year: 1997
  end-page: 186
  ident: b0035
  article-title: Mitogen-activated protein kinase pathways
  publication-title: Curr Opin Cell Biol
– volume: 26
  start-page: 9268
  year: 2006
  end-page: 9278
  ident: b0170
  article-title: Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling
  publication-title: Mol Cell Biol
– volume: 112
  start-page: 575
  year: 2003
  end-page: 587
  ident: b0025
  article-title: Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo
  publication-title: J Clin Invest
– volume: 257
  start-page: 223
  year: 2000
  end-page: 229
  ident: b0155
  article-title: Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells
  publication-title: Exp Cell Res.
– volume: 52
  start-page: 560
  year: 2008
  end-page: 568
  ident: b0115
  article-title: Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer
  publication-title: Histopathology
– volume: 21
  start-page: 19
  year: 2009
  end-page: 24
  ident: b0125
  article-title: Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas
  publication-title: Oncol Rep
– volume: 45
  start-page: 309
  year: 2009
  end-page: 316
  ident: b0010
  article-title: Global epidemiology of oral and oropharyngeal cancer
  publication-title: Oral Oncol
– volume: 16
  start-page: 571
  year: 2010
  end-page: 577
  ident: b0095
  article-title: Significance and relationship between Cripto-1 and p-STAT3 expression in gastric cancer and precancerous lesions
  publication-title: World J Gastroenterol
– volume: 84
  start-page: 1060
  year: 2007
  end-page: 1066
  ident: b0120
  article-title: Cripto-1 expression in uveal melanoma: an immunohistochemical study
  publication-title: Exp Eye Res
– volume: 63
  start-page: 1192
  year: 2003
  end-page: 1197
  ident: b0030
  article-title: A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src
  publication-title: Cancer Res
– volume: 198
  start-page: 31
  year: 2004
  end-page: 39
  ident: b0165
  article-title: Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells
  publication-title: J Cell Physiol
– volume: 13
  start-page: 2905
  year: 1999
  end-page: 2927
  ident: b0040
  article-title: Cellular survival: a play in three Akts
  publication-title: Genes Dev
– volume: 36
  start-page: 1002
  year: 2000
  end-page: 1007
  ident: b0110
  article-title: Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas
  publication-title: Eur J Cancer
– volume: 33
  start-page: 438
  year: 2007
  end-page: 443
  ident: b0105
  article-title: Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival
  publication-title: Eur J Surg Oncol
– volume: 7
  start-page: 199
  year: 2000
  end-page: 226
  ident: b0100
  article-title: The EGF–CFC family: novel epidermal growth factor-related proteins in development and cancer
  publication-title: Endocr Relat Cancer
– volume: 266
  start-page: 95
  year: 2001
  end-page: 105
  ident: b0160
  article-title: Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells
  publication-title: Exp Cell Res
– year: 2002
  ident: b0070
  article-title: AJCC cancer staging manual
– volume: 201
  start-page: 266
  year: 2004
  end-page: 276
  ident: b0065
  article-title: Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice
  publication-title: J Cell Physiol
– volume: 24
  start-page: 4094
  year: 2005
  end-page: 4105
  ident: b0145
  article-title: Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma
  publication-title: Oncogene
– volume: 5
  start-page: 440
  year: 1998
  end-page: 449
  ident: b0140
  article-title: Cripto: roles in mammary cell growth, survival, differentiation and transformation
  publication-title: Cell Death Differ
– reference: Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010.
– volume: 24
  start-page: 5731
  year: 2005
  end-page: 5741
  ident: b0045
  article-title: Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis
  publication-title: Oncogene
– volume: 22
  start-page: 133
  year: 2004
  end-page: 139
  ident: b0015
  article-title: Role of the cripto (EGF–CFC) family in embryogenesis and cancer
  publication-title: Growth Factors
– reference: .
– volume: 82
  start-page: 969
  year: 1991
  end-page: 973
  ident: b0080
  article-title: Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas
  publication-title: Jpn J Cancer Res
– volume: 36
  start-page: 563
  issue: 3
  year: 2010
  ident: 10.1016/j.oraloncology.2011.07.019_b0130
  article-title: TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer
  publication-title: Int J Oncol
– volume: 97
  start-page: 132
  issue: 2
  year: 2005
  ident: 10.1016/j.oraloncology.2011.07.019_b0060
  article-title: Role of human cripto-1 in tumor angiogenesis
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/dji011
– volume: 190
  start-page: 267
  issue: 3
  year: 2002
  ident: 10.1016/j.oraloncology.2011.07.019_b0135
  article-title: Cripto: a tumor growth factor and more
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.10072
– volume: 9
  start-page: 180
  issue: 2
  year: 1997
  ident: 10.1016/j.oraloncology.2011.07.019_b0035
  article-title: Mitogen-activated protein kinase pathways
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/S0955-0674(97)80061-0
– volume: 201
  start-page: 266
  issue: 2
  year: 2004
  ident: 10.1016/j.oraloncology.2011.07.019_b0065
  article-title: Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.20062
– volume: 7
  start-page: 199
  issue: 4
  year: 2000
  ident: 10.1016/j.oraloncology.2011.07.019_b0100
  article-title: The EGF–CFC family: novel epidermal growth factor-related proteins in development and cancer
  publication-title: Endocr Relat Cancer
  doi: 10.1677/erc.0.0070199
– volume: 33
  start-page: 438
  issue: 4
  year: 2007
  ident: 10.1016/j.oraloncology.2011.07.019_b0105
  article-title: Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2006.10.014
– volume: 130
  start-page: 6283
  issue: 25
  year: 2003
  ident: 10.1016/j.oraloncology.2011.07.019_b0175
  article-title: Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation
  publication-title: Development
  doi: 10.1242/dev.00859
– volume: 63
  start-page: 1192
  issue: 6
  year: 2003
  ident: 10.1016/j.oraloncology.2011.07.019_b0030
  article-title: A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src
  publication-title: Cancer Res
– volume: 65
  start-page: 51
  issue: 1
  year: 1996
  ident: 10.1016/j.oraloncology.2011.07.019_b0090
  article-title: Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(19960103)65:1<51::AID-IJC9>3.0.CO;2-0
– volume: 16
  start-page: 571
  issue: 5
  year: 2010
  ident: 10.1016/j.oraloncology.2011.07.019_b0095
  article-title: Significance and relationship between Cripto-1 and p-STAT3 expression in gastric cancer and precancerous lesions
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v16.i5.571
– volume: 84
  start-page: 1060
  issue: 6
  year: 2007
  ident: 10.1016/j.oraloncology.2011.07.019_b0120
  article-title: Cripto-1 expression in uveal melanoma: an immunohistochemical study
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2007.01.019
– volume: 266
  start-page: 95
  issue: 1
  year: 2001
  ident: 10.1016/j.oraloncology.2011.07.019_b0160
  article-title: Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells
  publication-title: Exp Cell Res
  doi: 10.1006/excr.2001.5195
– year: 2002
  ident: 10.1016/j.oraloncology.2011.07.019_b0070
– volume: 112
  start-page: 575
  issue: 4
  year: 2003
  ident: 10.1016/j.oraloncology.2011.07.019_b0025
  article-title: Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo
  publication-title: J Clin Invest
  doi: 10.1172/JCI17788
– volume: 24
  start-page: 5731
  issue: 37
  year: 2005
  ident: 10.1016/j.oraloncology.2011.07.019_b0045
  article-title: Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208918
– volume: 36
  start-page: 1002
  issue: 8
  year: 2000
  ident: 10.1016/j.oraloncology.2011.07.019_b0110
  article-title: Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas
  publication-title: Eur J Cancer
  doi: 10.1016/S0959-8049(00)00033-2
– volume: 52
  start-page: 560
  issue: 5
  year: 2008
  ident: 10.1016/j.oraloncology.2011.07.019_b0115
  article-title: Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2008.02971.x
– volume: 64
  start-page: 4018
  issue: 11
  year: 2004
  ident: 10.1016/j.oraloncology.2011.07.019_b0055
  article-title: Cripto: a novel target for antibody-based cancer immunotherapy
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-03-3888
– ident: 10.1016/j.oraloncology.2011.07.019_b0005
– volume: 21
  start-page: 19
  issue: 1
  year: 2009
  ident: 10.1016/j.oraloncology.2011.07.019_b0125
  article-title: Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas
  publication-title: Oncol Rep
– volume: 45
  start-page: 309
  issue: 4–5
  year: 2009
  ident: 10.1016/j.oraloncology.2011.07.019_b0010
  article-title: Global epidemiology of oral and oropharyngeal cancer
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2008.06.002
– volume: 5
  start-page: 440
  issue: 5
  year: 1998
  ident: 10.1016/j.oraloncology.2011.07.019_b0140
  article-title: Cripto: roles in mammary cell growth, survival, differentiation and transformation
  publication-title: Cell Death Differ
  doi: 10.1038/sj.cdd.4400368
– volume: 13
  start-page: 2905
  issue: 22
  year: 1999
  ident: 10.1016/j.oraloncology.2011.07.019_b0040
  article-title: Cellular survival: a play in three Akts
  publication-title: Genes Dev
  doi: 10.1101/gad.13.22.2905
– volume: 2
  start-page: 601
  issue: 3
  year: 1996
  ident: 10.1016/j.oraloncology.2011.07.019_b0050
  article-title: Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides
  publication-title: Clin Cancer Res
– volume: 52
  start-page: 3467
  issue: 12
  year: 1992
  ident: 10.1016/j.oraloncology.2011.07.019_b0085
  article-title: Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors
  publication-title: Cancer Res
– volume: 9
  start-page: 315
  year: 2009
  ident: 10.1016/j.oraloncology.2011.07.019_b0075
  article-title: Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-9-315
– volume: 82
  start-page: 969
  issue: 9
  year: 1991
  ident: 10.1016/j.oraloncology.2011.07.019_b0080
  article-title: Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas
  publication-title: Jpn J Cancer Res
  doi: 10.1111/j.1349-7006.1991.tb01929.x
– volume: 198
  start-page: 31
  issue: 1
  year: 2004
  ident: 10.1016/j.oraloncology.2011.07.019_b0165
  article-title: Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.10375
– volume: 211
  start-page: 36
  issue: 1
  year: 2007
  ident: 10.1016/j.oraloncology.2011.07.019_b0150
  article-title: Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice
  publication-title: J Pathol
  doi: 10.1002/path.2083
– volume: 24
  start-page: 4094
  issue: 25
  year: 2005
  ident: 10.1016/j.oraloncology.2011.07.019_b0145
  article-title: Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208417
– volume: 22
  start-page: 133
  issue: 3
  year: 2004
  ident: 10.1016/j.oraloncology.2011.07.019_b0015
  article-title: Role of the cripto (EGF–CFC) family in embryogenesis and cancer
  publication-title: Growth Factors
  doi: 10.1080/08977190410001723290
– volume: 257
  start-page: 223
  year: 2000
  ident: 10.1016/j.oraloncology.2011.07.019_b0155
  article-title: Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells
  publication-title: Exp Cell Res.
  doi: 10.1006/excr.2000.4881
– volume: 16
  start-page: 303
  issue: 7
  year: 2000
  ident: 10.1016/j.oraloncology.2011.07.019_b0020
  article-title: The EGF–CFC gene family in vertebrate development
  publication-title: Trends Genet
  doi: 10.1016/S0168-9525(00)02006-0
– volume: 26
  start-page: 9268
  issue: 24
  year: 2006
  ident: 10.1016/j.oraloncology.2011.07.019_b0170
  article-title: Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01168-06
SSID ssj0005150
Score 2.1522195
Snippet Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually, due...
Summary Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, remains a lethal disease in over 50% of cases diagnosed annually,...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1023
SubjectTerms Adult
Aged
Aged, 80 and over
Biological and medical sciences
Blotting, Western
Carcinoma, Squamous Cell - genetics
Carcinoma, Squamous Cell - metabolism
Case-Control Studies
Cell growth
Cell Movement
Cell Proliferation
Cell Transformation, Neoplastic - genetics
Cell Transformation, Neoplastic - metabolism
Cripto-1
Epithelium - metabolism
Female
GPI-Linked Proteins - genetics
GPI-Linked Proteins - metabolism
Hematology, Oncology and Palliative Medicine
Humans
Immunohistochemistry
Intercellular Signaling Peptides and Proteins - genetics
Intercellular Signaling Peptides and Proteins - metabolism
Male
Medical sciences
Middle Aged
Migration
Mouth Mucosa - metabolism
Mouth Neoplasms - genetics
Mouth Neoplasms - metabolism
Neoplasm Proteins - genetics
Neoplasm Proteins - metabolism
Oral squamous cell carcinoma
Otolaryngology
Otorhinolaryngology. Stomatology
Reverse Transcriptase Polymerase Chain Reaction
Tumors
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
Title The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1368837511007603
https://www.clinicalkey.es/playcontent/1-s2.0-S1368837511007603
https://dx.doi.org/10.1016/j.oraloncology.2011.07.019
https://www.ncbi.nlm.nih.gov/pubmed/21824804
https://www.proquest.com/docview/900629966
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1879-0593
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005150
  issn: 1368-8375
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1879-0593
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005150
  issn: 1368-8375
  databaseCode: ACRLP
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1879-0593
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005150
  issn: 1368-8375
  databaseCode: AIKHN
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect Freedom Collection 2013
  customDbUrl:
  eissn: 1879-0593
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005150
  issn: 1368-8375
  databaseCode: .~1
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1879-0593
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005150
  issn: 1368-8375
  databaseCode: AKRWK
  dateStart: 19970101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Na9RAFH-UCipI0fqVVpc5eE13k_lIFvFQtpZVaS9aqKdhZjIDW2yymt2DF_9235ska4sVFryGPDIz73vy3u8BvJkKn1e-KtNQepeKzIrUcmNR3V0eLPqIXFHv8Nm5ml-Ij5fycgdmQy8MlVX2tr-z6dFa90_G_WmOl4vF-HPGVYnplSTQs0JFxE9C_0KZPvp1o8wjk12nsCpTensAHo01XtQE39QRHvpnD-dZHEXUnbud1KOlafHoQjfz4t9BaXROp49hr48q2XG38Cew4-t9eHBClUA0zG0f7p_1_9CfwleUDEZFhawJbEY2o0kztqgZhoJstb6mUVlkABctM3XFYgFXB95BBLQX1n5fG7oyYHTtzxyNI6qba_MMLk7ff5nN037AQuowSlul0uUleahQcctREwOXHg9TVqLiKsNMLAhksXQ-z0zlCmWsV05UngcMKh3GMs9ht25q_xIYMpznRhUqYJpry2npM2-ss76QKnBeJDAdTlS7Hn2chmB800OZ2ZW-yQ1N3NCTQiM3EuAb2mWHwbEV1duBcXroMkW7qNFVbEVd3EXt217FW53pNtcT_ZcYJvBuQ3lLkrf-8uiWlG22nBNYniwnCbBB7DTaAuK0qT0yXU-pI5YS2ARedOL4hxjzSFFOxMF_ru4QHsZb9diN-Qp2Vz_W_jWGZSs7ino3gnvHHz7Nz38DmPs6xA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED9KCutgjK378j46PezVS2xZssPYQ8lW0rXJy1ronoQkS5Cy2mmdPOy_350tpyvrILBXw2H5vk---x3Ah3Hm0tKVRewLZ-MsMVlsuDZo7jb1BmNEKml2eDaX0_Ps24W42IFJPwtDbZXB93c-vfXW4ckwcHO4XCyG3xMuCyyvBIGe5ZIQP3czgT55ALuHxyfT-W2nRyK6YWFZxETQY4-2bV40B19XLUL0r4DomX9sgXfuj1OPlrpB7vlu7cW_89I2Ph09gcchsWSH3dmfwo6r9mHvCzUD0T63fXgwC7_Rn8EPVA5GfYWs9mxCbqOOE7aoGGaDbLW-om1Z5AMXDdNVydoerg6_gwjoW1hzvdZ0a8Do5p9Z2khU1Vf6OZwffT2bTOOwYyG2mKitYmHTgoKUL7nhaIyeC4f8FGVWcplgMeYzlLKwLk10aXOpjZM2Kx33mFdaTGdewKCqK_cKGMqcp1rm0mOla4px4RKnjTUuF9Jznkcw7jmqbAAgpz0YP1XfaXap_pSGImmoUa5QGhHwDe2yg-HYiupTLzjVD5qia1QYLbaizu-jdk2w8kYlqknVSP2liRF83lDeUeat33xwR8s2n5wSXp4oRhGwXu0UugOStK4cCl2NaSiWatgIXnbqeEuMpWRWjLLX_3m697A3PZudqtPj-ckbeNhesrfDmW9hsLpZu3eYpa3MQbDC3yXePW8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+Cripto-1+in+the+tumorigenesis+and+progression+of+oral+squamous+cell+carcinoma&rft.jtitle=Oral+oncology&rft.au=Yoon%2C+Hye-Jung&rft.au=Hong%2C+Ji-Soo&rft.au=Shin%2C+Wui-Jung&rft.au=Lee%2C+Yoo-Jin&rft.date=2011-11-01&rft.issn=1879-0593&rft.eissn=1879-0593&rft.volume=47&rft.issue=11&rft.spage=1023&rft_id=info:doi/10.1016%2Fj.oraloncology.2011.07.019&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F13688375%2FS1368837511X0012X%2Fcov150h.gif